Conversion of Nightingale Health Plc’s Series A shares and EMP shares to Series B shares
Company release, 19 May 2022 at 5.35 p.m. (EEST)
The Board of Directors of Nightingale Health Plc has in its meeting on February 2, 2022 and April 14, 2022, approved request of shareholders to convert 730,828 Series A and 280,537 EMP shares of Nightingale Health Plc to Series B shares in accordance with Article 5 in the Articles of Association.
The conversions of Series A shares to Series B shares were registered in the Trade Register on May 19, 2022. The converted shares will be listed on the Nasdaq First North Growth Market Finland marketplace together with the old shares as of May